First COVAX deliveries and campaigns begin
Data:
09/03/2021
On 24 February Ghana became the first country to receive vaccines shipped and delivered by COVAX. Vaccination campaigns began the following week. Despite the odds, we’ve proved that a multilateral, global solution to a pandemic is possible.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Vacinas Virais/provisão & distribuição, Programas de Imunização/organização & administração, Gana, COVID-19, Covax
10 days, 20 countries, more than 10 million doses of COVID-19 vaccines: COVAX rollout is here!
Data:
08/03/2021
#COVAX has delivered over 20M #COVID19 vaccine doses to 20 countries. In the next week, it will deliver 14.4M doses to a further 31 countries. This is encouraging progress, but the volume of doses being distributed through COVAX is still relatively small.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Vacinas Virais/provisão & distribuição, Programas de Imunização/organização & administração, COVID-19, Covax
What causes a virus to change and how to stop stronger COVID-19 variants from emerging
Data:
04/03/2021
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Stopping the spread at the source remains key. Current measures to reduce transmission – including frequent hand washing, wearing a mask, physi...
Ver detalhes
Betacoronavirus/genética, Infecções por Coronavirus/genética, Pneumonia Viral/genética, Pandemias/prevenção & controle, Comunicação em Saúde, Mutação/genética, COVID-19
To stop stronger COVID-19 variants from emerging we need to work together globally
Data:
04/03/2021
Ensuring equitable access to COVID-19 vaccines is more critical than ever to address the evolving pandemic. If some parts of the world eliminate the virus while it spreads widely in other areas, we all run the risk of stronger strains evolving. We’re only safe when everyone is safe.
Ver detalhes
Betacoronavirus/genética, Infecções por Coronavirus/genética, Pneumonia Viral/genética, Pandemias/prevenção & controle, Comunicação em Saúde, Mutação/genética, COVID-19
Stopping the spread of COVID-19 variants
Data:
04/03/2021
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Stopping the spread at the source remains key. Current measures to reduce transmission – including frequent hand washing, wearing a mask, physi...
Ver detalhes
Betacoronavirus/genética, Infecções por Coronavirus/genética, Pneumonia Viral/genética, Pandemias/prevenção & controle, Comunicação em Saúde, Mutação/genética, COVID-19
What causes a virus to change?
Data:
04/03/2021
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Ver detalhes
Betacoronavirus/genética, Infecções por Coronavirus/genética, Pneumonia Viral/genética, Pandemias/prevenção & controle, Comunicação em Saúde, Mutação/genética, COVID-19
Safety of COVID-19 vaccines: what we need to know
Data:
19/02/2021
As the world rolls out COVID-19 vaccines, many people are asking what to expect – in particular, are these vaccines safe? The answer is yes, but here’s a bit more information you may find useful.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19
Follow the journey of a vaccine
Data:
04/02/2021
From clinic trials and emergency use listing to production, transportation, storage and final administration by local health workers – follow the journey of a vaccine.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/normas, COVID-19
Here is how Pfizer/BioNTech COVID-19 vaccine should be used
Data:
03/02/2021
The Pfizer/BioNTech COVID-19 vaccine is the first vaccine to receive WHO validation for emergency use. Here is how it should be used.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19, Pfizer, BioNTech
The road to a COVID-19 vaccine
Data:
01/02/2021
Developing a vaccine is a long road full of checkpoints. Each phase designed to make sure it is both effective and safe. But with the whole world struggling to contain a pandemic, and unprecedented amounts of funding available, the road to finding the COVID-19 vaccine looks more like this.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19